Evofem Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CVI Investments, Inc.(0.9%),Heights Capital Management, Inc.(0.9%)
Evofem Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Zhang Yan
Evofem Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Kamdar Kim P.
Evofem Biosciences | D: Filing D
Evofem Biosciences | 5: Annual statement of changes in beneficial ownership of securities-Chief Financial Officer File Justin J.
Evofem Biosciences | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer PELLETIER SAUNDRA L
Evofem Biosciences | 3: Initial statement of beneficial ownership of securities-Chief Financial Officer Zhang Yan
Evofem Biosciences | D: Filing D
Evofem Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CVI Investments, Inc.(5.5%),Heights Capital Management, Inc.(5.5%)
Evofem Biosciences | D: Filing D
Evofem Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Todd Stewart Cox(0%),Kathy Overstreet Cox(0%)
Evofem Biosciences | 3: Initial statement of beneficial ownership of securities
Evofem Biosciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-Todd Stewart Cox(9.29%),Kathy Overstreet Cox(9.29%)
Evofem Biosciences | 3: Initial statement of beneficial ownership of securities-Chief Commercial Officer Atkinson Katherine Cocca
Evofem Biosciences | 4: Statement of changes in beneficial ownership of securities
Evofem Biosciences | 4: Statement of changes in beneficial ownership of securities
Evofem Biosciences | 4: Statement of changes in beneficial ownership of securities
Evofem Biosciences | 4: Statement of changes in beneficial ownership of securities
Evofem Biosciences | 4: Statement of changes in beneficial ownership of securities
Evofem Biosciences | 4: Statement of changes in beneficial ownership of securities
No Data